nach oben

Translational Stroke Research

Erschienen in:

01.06.2015 | Editorial

Aneurysmal Subarachnoid Hemorrhage—Status Quo and Perspective

verfasst von: Nima Etminan

Erschienen in: Translational Stroke Research | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Excerpt

Aneurysmal subarachnoid hemorrhage (SAH) accounts for about 5 % of all strokes and continues to be a major cause of morbidity and mortality, especially in younger patients (mean age of 52). The global incidence of SAH is 9 per 100,000 per year with some regional variations [1]. Data from population-based studies suggests a distinct decrease in case fatality (0.9 % per year) over the past four decades to about 30 %, which is likely originated in earlier and more advanced aneurysm repair as well as improved neurocritical care of SAH patients following aneurysm repair [2]. Nevertheless, the incidence of poor functional outcome in SAH patients remains high (about one third of patients). The main determinants for poor outcome after SAH are the degree of early brain injury (EBI) and the incidence of delayed cerebral ischemia (DCI) (see below) [3, 4]. …

de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78(12):1365–72. doi:10.1136/jnnp.2007.117655.CrossRefPubMedCentralPubMed

Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology. 2010;74(19):1494–501. doi:10.1212/WNL.0b013e3181dd42b3.CrossRefPubMedCentralPubMed

Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;60(4):658–67. doi:10.1227/01.NEU.0000255396.23280.31. discussion 67.CrossRefPubMed

Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924–9. doi:10.1161/STROKEAHA.110.597914.CrossRefPubMed

Bruder N, Rabinstein A, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H. Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):257–69. doi:10.1007/s12028-011-9598-4.CrossRefPubMed

Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013;79(2):307–12. doi:10.1016/j.wneu.2012.06.023.CrossRefPubMed

Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58. doi:10.1038/nrneurol.2013.246.CrossRefPubMed

Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res. 2013;4(4):432–46. doi:10.1007/s12975-013-0257-2.CrossRefPubMedCentralPubMed

Etminan N, Beseoglu K, Eicker SO, Turowski B, Steiger HJ, Hanggi D. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage. Stroke. 2013;44(8):2162–8. doi:10.1161/STROKEAHA.113.001790.CrossRefPubMed

10.

Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T, et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab. 1998;18(9):978–90. doi:10.1097/00004647-199809000-00007.CrossRefPubMed

11.

Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain. 2009;132(Pt 7):1866–81. doi:10.1093/brain/awp102.CrossRefPubMedCentralPubMed

12.

Etminan N, Vergouwen MD, Macdonald RL. Angiographic vasospasm versus cerebral infarction as outcome measures after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:33–40. doi:10.1007/978-3-7091-1192-5_8.PubMed

13.

Friedrich B, Muller F, Feiler S, Scholler K, Plesnila N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study. J Cereb Blood Flow Metab. 2012;32(3):447–55. doi:10.1038/jcbfm.2011.154.CrossRefPubMedCentralPubMed

14.

Park KW, Metais C, Dai HB, Comunale ME, Sellke FW. Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg. 2001;92(4):990–6.CrossRefPubMed

15.

Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(11):1761–70. doi:10.1038/jcbfm.2008.74.CrossRefPubMed

16.

Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–5. doi:10.1161/STROKEAHA.110.589275.CrossRefPubMed

17.

Yundt KD, Grubb Jr RL, Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab. 1998;18(4):419–24. doi:10.1097/00004647-199804000-00010.CrossRefPubMed

18.

Brathwaite S, Macdonald RL. Current management of delayed cerebral ischemia: update from results of recent clinical trials. Transl Stroke Res. 2014;5(2):207–26. doi:10.1007/s12975-013-0316-8.CrossRefPubMed

19.

Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31(6):1443–51. doi:10.1038/jcbfm.2011.7.CrossRefPubMedCentralPubMed

20.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618–25.CrossRefPubMed

21.

Vergouwen MD. Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies. Neurocrit Care. 2011;15(2):308–11. doi:10.1007/s12028-011-9586-8.CrossRefPubMed

22.

Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL. Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2011;31(7):1545–53. doi:10.1038/jcbfm.2011.56.CrossRefPubMedCentralPubMed

23.

Chen S, Ma Q, Krafft PR, Chen Y, Tang J, Zhang J, et al. P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats. Crit Care Med. 2013;41(12):e466–74. doi:10.1097/CCM.0b013e31829a8246.CrossRefPubMed

24.

Chou SH, Feske SK, Simmons SL, Konigsberg RG, Orzell SC, Marckmann A, et al. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011;2(4):600–7. doi:10.1007/s12975-011-0117-x.CrossRefPubMedCentralPubMed

25.

Fujii M, Sherchan P, Soejima Y, Hasegawa Y, Flores J, Doycheva D, et al. Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. Exp Neurol. 2014;261:396–403. doi:10.1016/j.expneurol.2014.07.005.CrossRefPubMed

26.

Murakami K, Koide M, Dumont TM, Russell SR, Tranmer BI, Wellman GC. Subarachnoid hemorrhage induces gliosis and increased expression of the pro-inflammatory cytokine high mobility group box 1 protein. Transl Stroke Res. 2011;2(1):72–9. doi:10.1007/s12975-010-0052-2.CrossRefPubMedCentralPubMed

27.

Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM, Hong Y. Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-kappaB-dependent inflammatory/MMP-9 pathway. CNS Neurosci Ther. 2014;20(2):182–5. doi:10.1111/cns.12194.CrossRefPubMed

28.

Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, Taki W, Suzuki H. Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats. Transl Stroke Res. 2014;5(2):238–47. doi:10.1007/s12975-014-0333-2.CrossRefPubMed

29.

Simard JM, Tosun C, Ivanova S, Kurland DB, Hong C, Radecki L, et al. Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage. Transl Stroke Res. 2012;3 Suppl 1:155–65. doi:10.1007/s12975-012-0166-9.CrossRefPubMedCentralPubMed

30.

Yan J, Manaenko A, Chen S, Klebe D, Ma Q, Caner B, et al. Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage. Stroke. 2013;44(5):1410–7. doi:10.1161/STROKEAHA.113.678474.CrossRefPubMedCentralPubMed

31.

Etminan N, Macdonald RL, Davis C, Burton K, Steiger HJ, Hanggi D. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2015;120:281–6. doi:10.1007/978-3-319-04981-6_47.PubMed

32.

Kasuya H. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo. Acta Neurochir Suppl. 2011;110(Pt 2):165–7. doi:10.1007/978-3-7091-0356-2_30.PubMed

33.

Lei Q, Li S, Zheng R, Xu K, Li S. Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage. Neuroradiology. 2015;57(1):63–70. doi:10.1007/s00234-014-1435-y.CrossRefPubMed

34.

Tso MK, Macdonald RL. Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit. Transl Stroke Res. 2014;5(2):174–89. doi:10.1007/s12975-014-0323-4.CrossRefPubMed

35.

Buhler D, Schuller K, Plesnila N. Protocol for the induction of subarachnoid hemorrhage in mice by perforation of the Circle of Willis with an endovascular filament. Transl Stroke Res. 2014;5(6):653–9. doi:10.1007/s12975-014-0366-6.CrossRefPubMedCentralPubMed

36.

Guresir E, Schuss P, Borger V, Vatter H. Experimental subarachnoid hemorrhage: double cisterna magna injection rat model-assessment of delayed pathological effects of cerebral vasospasm. Transl Stroke Res. 2015. doi:10.1007/s12975-015-0392-z.PubMed

37.

Kikkawa Y, Kurogi R, Sasaki T. The single and double blood injection rabbit subarachnoid hemorrhage model. Transl Stroke Res. 2015;6(1):88–97. doi:10.1007/s12975-014-0375-5.CrossRefPubMed

38.

Mori K. Double cisterna magna blood injection model of experimental subarachnoid hemorrhage in dogs. Transl Stroke Res. 2014;5(6):647–52. doi:10.1007/s12975-014-0356-8.CrossRefPubMed

39.

Pluta RM, Bacher J, Skopets B, Hoffmann V. A non-human primate model of aneurismal subarachnoid hemorrhage (SAH). Transl Stroke Res. 2014;5(6):681–91. doi:10.1007/s12975-014-0371-9.CrossRefPubMed

40.

Baharoglu MI, Germans MR, Rinkel GJ, Algra A, Vermeulen M, van Gijn J, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2013;8, CD001245. doi:10.1002/14651858.CD001245.pub2.PubMed

41.

Germans MR, Post R, Coert BA, Rinkel GJ, Vandertop WP, Verbaan D. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial. Trials. 2013;14:143. doi:10.1186/1745-6215-14-143.CrossRefPubMedCentralPubMed

42.

Cremers CH, van der Schaaf IC, Wensink E, Greving JP, Rinkel GJ, Velthuis BK, et al. CT perfusion and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2014;34(2):200–7. doi:10.1038/jcbfm.2013.208.CrossRefPubMedCentralPubMed

43.

Rawal S, Barnett C, John-Baptiste A, Thein HH, Krings T, Rinkel GJ. Effectiveness of diagnostic strategies in suspected delayed cerebral ischemia: a decision analysis. Stroke. 2015;46(1):77–83. doi:10.1161/STROKEAHA.114.005916.CrossRefPubMed

44.

Washington CW, Zipfel GJ. Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit Care. 2011;15(2):312–7. doi:10.1007/s12028-011-9594-8.CrossRefPubMed

45.

Etminan N, Beseoglu K, Heiroth HJ, Turowski B, Steiger HJ, Hanggi D. Early perfusion computerized tomography imaging as a radiographic surrogate for delayed cerebral ischemia and functional outcome after subarachnoid hemorrhage. Stroke. 2013;44(5):1260–6. doi:10.1161/STROKEAHA.111.675975.CrossRefPubMed

46.

Dhar R, Scalfani MT, Zazulia AR, Videen TO, Derdeyn CP, Diringer MN. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg. 2012;116(3):648–56. doi:10.3171/2011.9.JNS11691.CrossRefPubMedCentralPubMed

47.

Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care. 2009;15(2):83–6. doi:10.1097/MCC.0b013e32832922d1.CrossRefPubMed

48.

Treggiari MM, Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):329–35. doi:10.1007/s12028-011-9589-5.CrossRefPubMed

49.

Abruzzo T, Moran C, Blackham KA, Eskey CJ, Lev R, Meyers P, et al. Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 2012;4(3):169–77. doi:10.1136/neurintsurg-2011-010248.CrossRefPubMed

50.

Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;3, CD000277. doi:10.1002/14651858.CD000277.pub3.PubMed

51.

Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD, Collaborators S. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014;13(7):666–75. doi:10.1016/S1474-4422(14)70084-5.CrossRefPubMed

52.

Wong GK, Chan DY, Siu DY, Zee BC, Poon WS, Chan MT, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial. Stroke. 2015;46(2):382–8. doi:10.1161/STROKEAHA.114.007006.CrossRefPubMed

53.

Kreiter KT, Mayer SA, Howard G, Knappertz V, Ilodigwe D, Sloan MA, et al. Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke. 2009;40(7):2362–7. doi:10.1161/STROKEAHA.109.547331.CrossRefPubMed

54.

Jaja BN, Attalla D, Macdonald RL, Schweizer TA, Cusimano MD, Etminan N, et al. The Subarachnoid Hemorrhage International Trialists (SAHIT) Repository: advancing clinical research in subarachnoid hemorrhage. Neurocrit Care. 2014;21(3):551–9. doi:10.1007/s12028-014-9990-y.CrossRefPubMed

55.

Macdonald RL, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, et al. Subarachnoid Hemorrhage International Trialists data repository (SAHIT). World Neurosurg. 2013;79(3–4):418–22. doi:10.1016/j.wneu.2013.01.006.CrossRefPubMed

56.

Macdonald RL, Jaja B, Cusimano MD, Etminan N, Hanggi D, Hasan D, et al. SAHIT Investigators—on the outcome of some subarachnoid hemorrhage clinical trials. Transl Stroke Res. 2013;4(3):286–96. doi:10.1007/s12975-012-0242-1.CrossRefPubMed

57.

Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519–36. doi:10.1161/STROKEAHA.110.581975.CrossRefPubMed

58.

Sheldon S, Macdonald RL, Cusimano M, Spears J, Schweizer TA. Long-term consequences of subarachnoid hemorrhage: examining working memory. J Neurol Sci. 2013;332(1–2):145–7. doi:10.1016/j.jns.2013.06.021.CrossRefPubMed

59.

Sheldon S, Macdonald RL, Schweizer TA. Free recall memory performance after aneurysmal subarachnoid hemorrhage. J Int Neuropsychol Soc : JINS. 2012;18(2):334–42. doi:10.1017/S1355617711001780.CrossRefPubMed

60.

Hanggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, et al. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage. Neurocrit Care. 2015. doi:10.1007/s12028-015-0112-2.PubMed

61.

Rasmussen R, Juhler M, Wetterslev J. Effects of continuous prostacyclin infusion on regional blood flow and cerebral vasospasm following subarachnoid haemorrhage: statistical analysis plan for a randomized controlled trial. Trials. 2014;15:228. doi:10.1186/1745-6215-15-228.CrossRefPubMedCentralPubMed

62.

Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med. 2010;38(5):1284–90. doi:10.1097/CCM.0b013e3181d9da1e.PubMed

Titel: Aneurysmal Subarachnoid Hemorrhage—Status Quo and Perspective
verfasst von: Nima Etminan
Publikationsdatum: 01.06.2015
Verlag: Springer US
Erschienen in: Translational Stroke Research / Ausgabe 3/2015
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-015-0398-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Aneurysmal Subarachnoid Hemorrhage—Status Quo and Perspective

Excerpt

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Increased Brain Perfusion Persists over the First Month of Life in Term Asphyxiated Newborns Treated with Hypothermia: Does it Reflect Activated Angiogenesis?

Atherosclerosis-Related Circulating MicroRNAs as a Predictor of Stroke Recurrence

Depressive-Like Behaviors in a Rat Model of Chronic Cerebral Hypoperfusion

Experimental Subarachnoid Hemorrhage: Double Cisterna Magna Injection Rat Model—Assessment of Delayed Pathological Effects of Cerebral Vasospasm

Bcl-2 Phosphorylation Triggers Autophagy Switch and Reduces Mitochondrial Damage in Limb Remote Ischemic Conditioned Rats After Ischemic Stroke

Iron-Induced Necrotic Brain Cell Death in Rats with Different Aerobic Capacity

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie